| Primary |
| Abortion Induced |
18.3% |
| Local Anaesthesia |
14.9% |
| Anaesthesia |
13.4% |
| Product Used For Unknown Indication |
6.4% |
| Drug Use For Unknown Indication |
5.4% |
| Dupuytren's Contracture |
5.4% |
| Analgesia |
5.0% |
| Nerve Block |
5.0% |
| Hypertension |
4.5% |
| Cardiac Failure Congestive |
3.0% |
| Attention Deficit/hyperactivity Disorder |
2.5% |
| Induction Of Anaesthesia |
2.5% |
| Eye Pain |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Induction And Maintenance Of Anaesthesia |
2.0% |
| Peritoneal Dialysis |
2.0% |
| Anaesthesia Procedure |
1.5% |
| Bleeding |
1.5% |
| Bronchoscopy |
1.5% |
| Convulsion |
1.5% |
|
| Off Label Use |
37.0% |
| Methaemoglobinaemia |
13.0% |
| Cardiac Arrest |
4.6% |
| Convulsion |
3.7% |
| Nausea |
3.7% |
| Respiratory Failure |
3.7% |
| Drug Hypersensitivity |
2.8% |
| Hypoaesthesia |
2.8% |
| Medication Error |
2.8% |
| Overdose |
2.8% |
| Pain |
2.8% |
| Posterior Reversible Encephalopathy Syndrome |
2.8% |
| Somnolence |
2.8% |
| Syncope |
2.8% |
| Urticaria |
2.8% |
| Anaphylactic Shock |
1.9% |
| Bronchospasm |
1.9% |
| Death |
1.9% |
| Electrocardiogram St Segment Elevation |
1.9% |
| Hypertension |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
24.7% |
| Hypertension |
13.0% |
| Induction Of Anaesthesia |
10.1% |
| Local Anaesthesia |
6.9% |
| Anaesthesia |
6.1% |
| Cardiac Failure Congestive |
4.9% |
| Drug Use For Unknown Indication |
4.5% |
| Cystitis Interstitial |
4.0% |
| Back Pain |
3.2% |
| Pain |
3.2% |
| Sedation |
3.2% |
| Blood Pressure |
2.4% |
| Epidural Analgesia |
2.0% |
| Maintenance Of Anaesthesia |
2.0% |
| Arthralgia |
1.6% |
| Arthritis |
1.6% |
| Eye Pain |
1.6% |
| Hiv Infection |
1.6% |
| Intervertebral Disc Disorder |
1.6% |
| Spinal Anaesthesia |
1.6% |
|
| Swollen Tongue |
14.3% |
| Drug Hypersensitivity |
8.9% |
| Endophthalmitis |
7.1% |
| Restlessness |
7.1% |
| Blindness Transient |
5.4% |
| Prinzmetal Angina |
5.4% |
| Tracheostomy |
5.4% |
| Vision Blurred |
5.4% |
| Atrial Fibrillation |
3.6% |
| Drug Toxicity |
3.6% |
| Face Oedema |
3.6% |
| Laryngeal Oedema |
3.6% |
| Maternal Exposure During Pregnancy |
3.6% |
| Mental Status Changes |
3.6% |
| Pain |
3.6% |
| Partial Seizures |
3.6% |
| Pyrexia |
3.6% |
| Respiratory Arrest |
3.6% |
| Syncope |
3.6% |
| Anaphylactic Reaction |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
55.8% |
| Drug Use For Unknown Indication |
7.9% |
| Hypertension |
6.3% |
| Fabry's Disease |
4.2% |
| Pain |
3.6% |
| Prostate Cancer |
2.4% |
| Constipation |
2.3% |
| Premedication |
1.9% |
| Prophylaxis |
1.8% |
| Nausea |
1.8% |
| Diabetes Mellitus |
1.7% |
| Colitis Ulcerative |
1.4% |
| Scleroderma |
1.4% |
| Angina Pectoris |
1.3% |
| Colorectal Cancer |
1.2% |
| Depression |
1.1% |
| Gastritis Prophylaxis |
1.1% |
| Multiple Myeloma |
1.1% |
| Neoplasm Malignant |
1.0% |
| Stomatitis |
0.9% |
|
| Eye Inflammation |
10.5% |
| Osteonecrosis |
9.7% |
| Vision Blurred |
9.7% |
| Nausea |
7.3% |
| Liver Function Test Abnormal |
6.5% |
| Fungal Infection |
5.6% |
| Pain |
5.6% |
| Spinal Compression Fracture |
4.8% |
| Thrombocytopenia |
4.8% |
| Vomiting |
4.8% |
| Urticaria |
4.0% |
| Weight Increased |
4.0% |
| Anal Abscess |
3.2% |
| Hyperglycaemia |
3.2% |
| Pulmonary Hypertension |
3.2% |
| Rhabdomyolysis |
3.2% |
| Deafness |
2.4% |
| Deafness Neurosensory |
2.4% |
| Electrocardiogram Qt Prolonged |
2.4% |
| Fatigue |
2.4% |
|
| Interacting |
| Sedation |
40.0% |
| Analgesic Therapy |
20.0% |
| Depression |
20.0% |
| Atrial Fibrillation |
10.0% |
| Ulcer |
10.0% |
|
| Neurotoxicity |
55.6% |
| Serotonin Syndrome |
22.2% |
| Convulsion |
11.1% |
| International Normalised Ratio Increased |
11.1% |
|
